Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • DESeq for a small sets of sequences without replicates

    Hi SEQanswers community.
    I was trying to use the DESeq package to analyse differential expression between two RNASeq experiments, but these sets are rather small (around 130 points) and are very variable. On the top, I have no replicates for neither of two sets.

    The results seem quite awkward, DESeq having chosen the points with very low number of reads as the ones with the lowest p-value.

    I hence wondered whether DESeq is suited whatsoever for the use on the small datasets with no replicates.

    Thanks in advance for any insight,
    Ana

  • #2
    With no replicates it is quite difficult. My experience with no replicates was that I got lot of my entries with high p-value and it was useless.
    ------------
    SMART - bioinfo.uni-plovdiv.bg

    Comment


    • #3
      Hi vbaev.
      Thanks for your answer. Yes, first all the p-values are quite high and also, those with pow one have a low read count.
      Do you know whether it is due to the lack of replicates only or the combination of the lack of replicates and low size of the set of tags.

      Thanks again,
      Ana

      Comment


      • #4
        I do not know in your case, but in my case was miR analysis and I got no replicates, than I used chi-square test after normalization and p-values are more nicer. I also added a small number to each entry that way the ratio between low read counts will be not so significant (http://bib.oxfordjournals.org/content/10/5/490.abstract)

        But for RNAseq maybe is different?
        ------------
        SMART - bioinfo.uni-plovdiv.bg

        Comment


        • #5
          Hi.
          In my case it is also microRNA analysis. I will check this paper you sent.
          Thanks.
          Ana

          Comment


          • #6
            Originally posted by vebaev View Post
            I do not know in your case, but in my case was miR analysis and I got no replicates, than I used chi-square test after normalization and p-values are more nicer. I also added a small number to each entry that way the ratio between low read counts will be not so significant (http://bib.oxfordjournals.org/content/10/5/490.abstract)

            But for RNAseq maybe is different?
            Of course you get more hits with a chi-squared test, because this means that you set the biological variance to be zero. Your results will not be reproducible, though.

            I've explained this at length in this post: http://seqanswers.com/forums/showpos...04&postcount=2

            In the terminology of this post, you tested for question (A) but should have tested for question (B).

            Simon

            Comment


            • #7
              Thanks Simon for clearing this,
              I'm not so into statistics, so I just used the methid with chi-square like they use it in several miRNA tools for example miRNAKey (http://bioinformatics.oxfordjournals...6/20/2615.long)

              Vesko
              ------------
              SMART - bioinfo.uni-plovdiv.bg

              Comment

              Latest Articles

              Collapse

              • seqadmin
                Understanding Genetic Influence on Infectious Disease
                by seqadmin




                During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

                Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
                09-09-2024, 10:59 AM
              • seqadmin
                Addressing Off-Target Effects in CRISPR Technologies
                by seqadmin






                The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
                08-27-2024, 04:44 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by seqadmin, 09-06-2024, 08:02 AM
              0 responses
              143 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 09-03-2024, 08:30 AM
              0 responses
              147 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 08-27-2024, 04:40 AM
              0 responses
              158 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 08-22-2024, 05:00 AM
              0 responses
              402 views
              0 likes
              Last Post seqadmin  
              Working...
              X